Endothelin Receptor Antagonist [EPC]

200312 reported adverse events

Drugs of this class: MACITENTAN AMBRISENTAN APROCITENTAN MACITENTAN AND TADALAFIL SPARSENTAN

These side effects are most commonly reported by patients taking drugs of the Endothelin Receptor Antagonist [EPC] class:

# Side effect Count
0 DYSPNOEA 31222
1 HEADACHE 19439
2 DEATH 18758
3 DIARRHOEA 13818
4 NAUSEA 12932
5 FATIGUE 12552
6 DIZZINESS 12077
7 PNEUMONIA 11879
8 FLUID RETENTION 9356
9 MALAISE 9015
See all common reactions for Endothelin Receptor Antagonist [EPC]

Drugs of the Endothelin Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRANSPLANT EVALUATION 277 0.5453
1 CATHETER SITE PRURITUS 474 0.5399
2 CATHETER MANAGEMENT 473 0.5261
3 CATHETER SITE RASH 220 0.4867
4 DEVICE MAINTENANCE ISSUE 269 0.4575
5 PULMONARY ARTERIAL HYPERTENSION 6558 0.4521
6 OXYGEN CONSUMPTION INCREASED 944 0.3946
7 INFUSION SITE INFECTION 889 0.3822
8 PULMONARY ARTERIAL PRESSURE INCREASED 613 0.3761
9 CATHETER SITE DISCHARGE 414 0.3683
See all enriched reactions for Endothelin Receptor Antagonist [EPC]